{"id":1224,"date":"2026-02-12T14:37:09","date_gmt":"2026-02-12T22:37:09","guid":{"rendered":"https:\/\/cloudbreaktstg.wpenginepowered.com\/?page_id=1224"},"modified":"2026-04-02T14:01:46","modified_gmt":"2026-04-02T21:01:46","slug":"pterygium-therapy","status":"publish","type":"page","link":"https:\/\/cloudbreakpharma.com\/zh_hk\/our-focus\/pterygium-therapy\/","title":{"rendered":"Pterygium Therapy"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"1224\" class=\"elementor elementor-1224\" data-elementor-post-type=\"page\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-26c5ad8 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"26c5ad8\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-243e92d\" data-id=\"243e92d\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-0e5adc3 elementor-widget elementor-widget-text-editor\" data-id=\"0e5adc3\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h1 style=\"text-align: center;\"><strong><span style=\"color: #ffffff;\">First Pharmacologic Approach to Target Pterygium\u2019s Root Cause<\/span><\/strong><\/h1>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-1ffd503 elementor-section-content-middle elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"1ffd503\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-66 elementor-top-column elementor-element elementor-element-b1bb2b1\" data-id=\"b1bb2b1\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-402f30d elementor-widget elementor-widget-text-editor\" data-id=\"402f30d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h3><span style=\"color: #ffffff;\"><strong>Cloudbreak Pharma<\/strong> is pioneering the first FDA-approvable pharmaceutical treatment for pterygium \u2014 a condition affecting over 15 million people in the U.S. with no approved pharmacological options. Our lead program, <strong>CBT-001<\/strong>, is a proprietary <strong>Multi-Kinase Inhibitor (MKI)<\/strong> eye drop designed to simultaneously target the <strong>multiple signaling pathways<\/strong> that drive the abnormal fibrovascular changes of pterygium, rather than simply masking symptoms.<\/span><\/h3>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-33 elementor-top-column elementor-element elementor-element-aafe5fc\" data-id=\"aafe5fc\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-fcdf741 elementor-widget__width-initial elementor-widget elementor-widget-image\" data-id=\"fcdf741\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"800\" height=\"800\" src=\"https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/CB-PT-Eyedropper-with-PT-square-1024x1024.jpg\" class=\"attachment-large size-large wp-image-1285\" alt=\"\" srcset=\"https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/CB-PT-Eyedropper-with-PT-square-1024x1024.jpg 1024w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/CB-PT-Eyedropper-with-PT-square-300x300.jpg 300w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/CB-PT-Eyedropper-with-PT-square-150x150.jpg 150w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/CB-PT-Eyedropper-with-PT-square-768x768.jpg 768w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/CB-PT-Eyedropper-with-PT-square-12x12.jpg 12w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/CB-PT-Eyedropper-with-PT-square.jpg 1247w\" sizes=\"(max-width: 800px) 100vw, 800px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-3ac697c elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"3ac697c\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-3f9c0a9\" data-id=\"3f9c0a9\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-63193f4 elementor-widget elementor-widget-spacer\" data-id=\"63193f4\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-1c6fb63 elementor-widget elementor-widget-text-editor\" data-id=\"1c6fb63\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h2 style=\"text-align: center;\"><span style=\"color: #375e6f;\"><strong>MULTI-KINASE INHIBITOR PLATFORM<\/strong><\/span><\/h2><h4 style=\"text-align: center;\">TARGETING THE FULL DISEASE CASCADE, NOT JUST ONE PATHWAY<\/h4>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-58cd723 elementor-widget elementor-widget-text-editor\" data-id=\"58cd723\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p style=\"text-align: center;\">Current management of pterygium is aimed at easing symptoms and controlling surface inflammation rather than eliminating the underlying degenerative change. Lubricating drops, anti-inflammatory medications, and environmental modifications can reduce irritation, but relief is often incomplete and temporary, and the visible lesion typically remains. In more bothersome cases, patients may still struggle with redness, discomfort, or contact lens intolerance, and only a small minority are offered surgery for persistent inflammation or c<span data-olk-copy-source=\"MessageBody\">oncerns about appearance<\/span>, underscoring the need for better, targeted therapies.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-70ca2dc elementor-align-center elementor-widget elementor-widget-button\" data-id=\"70ca2dc\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/cloudbreakpharma.com\/technology\/mki\/\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Learn more about MKI's<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-0924855 elementor-widget elementor-widget-spacer\" data-id=\"0924855\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-1ac53de elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"1ac53de\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-f783d56\" data-id=\"f783d56\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-7a8fb41 elementor-widget elementor-widget-spacer\" data-id=\"7a8fb41\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-05953dc elementor-widget elementor-widget-text-editor\" data-id=\"05953dc\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h3><strong>How Pterygium Develops<\/strong><\/h3><p>Chronic UV radiation exposure initiates a cascade of cellular damage in the conjunctival tissue:<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-535b45c elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"535b45c\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-top-column elementor-element elementor-element-e2589b4\" data-id=\"e2589b4\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-eda52aa elementor-widget__width-initial elementor-widget elementor-widget-image\" data-id=\"eda52aa\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" width=\"2000\" height=\"660\" src=\"https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/newarc_ai_Disease-Progression-Labeled-1.jpg\" class=\"attachment-full size-full wp-image-1189\" alt=\"\" srcset=\"https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/newarc_ai_Disease-Progression-Labeled-1.jpg 2000w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/newarc_ai_Disease-Progression-Labeled-1-300x99.jpg 300w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/newarc_ai_Disease-Progression-Labeled-1-1024x338.jpg 1024w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/newarc_ai_Disease-Progression-Labeled-1-768x253.jpg 768w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/newarc_ai_Disease-Progression-Labeled-1-1536x507.jpg 1536w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/newarc_ai_Disease-Progression-Labeled-1-18x6.jpg 18w\" sizes=\"(max-width: 2000px) 100vw, 2000px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-top-column elementor-element elementor-element-9f30c68\" data-id=\"9f30c68\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-037039f elementor-widget elementor-widget-text-editor\" data-id=\"037039f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><strong>UV Exposure:<\/strong> DNA damage to conjunctival cells and limbal fibroblasts<\/p><p><strong>Cell Activation: <\/strong>\u00a0Upregulation of inflammatory cytokines (TNF-\u03b1, IL-6, IL-8)<\/p><p><strong>Growth Factor Release: <\/strong>\u00a0Overexpression of VEGF, PDGF, FGF, TGF-\u03b2<\/p><p><strong>Vascularization &amp; Fibrosis:<\/strong>\u00a0Abnormal fibrovascular deposit formation<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-8c86c57 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"8c86c57\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-1f7f1d1\" data-id=\"1f7f1d1\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-c7edc0f elementor-widget elementor-widget-spacer\" data-id=\"c7edc0f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-af6f103 elementor-widget__width-initial elementor-widget elementor-widget-text-editor\" data-id=\"af6f103\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h3 style=\"text-align: left;\"><strong>How CBT-001 Intervenes<\/strong><\/h3><p style=\"text-align: left;\">Pterygium&#8217;s overlapping signaling pathways render <strong>single-target therapies ineffective<\/strong> \u2014 compensatory mechanisms allow disease to persist. <strong>Cloudbreak&#8217;s MKI<\/strong> platform overcomes this through simultaneous <strong>multi-pathway inhibition.<\/strong>&#8220;<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-6c61377 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"6c61377\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-top-column elementor-element elementor-element-6b00c38\" data-id=\"6b00c38\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-b2b7034 elementor-widget__width-initial elementor-widget elementor-widget-image\" data-id=\"b2b7034\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" width=\"2000\" height=\"660\" src=\"https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/newarc_ai_2-Disease-Progression-Labeled-Stacked-001.jpg\" class=\"attachment-full size-full wp-image-1270\" alt=\"\" srcset=\"https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/newarc_ai_2-Disease-Progression-Labeled-Stacked-001.jpg 2000w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/newarc_ai_2-Disease-Progression-Labeled-Stacked-001-300x99.jpg 300w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/newarc_ai_2-Disease-Progression-Labeled-Stacked-001-1024x338.jpg 1024w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/newarc_ai_2-Disease-Progression-Labeled-Stacked-001-768x253.jpg 768w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/newarc_ai_2-Disease-Progression-Labeled-Stacked-001-1536x507.jpg 1536w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/newarc_ai_2-Disease-Progression-Labeled-Stacked-001-18x6.jpg 18w\" sizes=\"(max-width: 2000px) 100vw, 2000px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-top-column elementor-element elementor-element-194a78d\" data-id=\"194a78d\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-f18317c elementor-widget elementor-widget-text-editor\" data-id=\"f18317c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p style=\"text-align: left;\"><strong>CBT-001 targets:<\/strong><\/p><p style=\"text-align: left;\"><strong>VEGFRs<\/strong>: Inhibits pathological angiogenesis\/vascularization<\/p><p style=\"text-align: left;\"><strong>PDGFRs<\/strong>: Reduces fibroblast activation and connective tissue remodeling<\/p><p style=\"text-align: left;\"><strong>FGFRs<\/strong>: Suppresses further inflammatory cell signaling<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-b0efe80 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"b0efe80\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-top-column elementor-element elementor-element-201bfac\" data-id=\"201bfac\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap\">\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-top-column elementor-element elementor-element-212084f\" data-id=\"212084f\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap\">\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-d43774b elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"d43774b\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-549773c\" data-id=\"549773c\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-d4a02a0 elementor-widget elementor-widget-spacer\" data-id=\"d4a02a0\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-dbcb79f elementor-widget elementor-widget-text-editor\" data-id=\"dbcb79f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h2 style=\"text-align: center;\"><span style=\"color: #375e6f;\"><strong>CBT-001: CLINICAL PROOF OF CONCEPT<\/strong><\/span><\/h2><h4 style=\"text-align: center;\">Phase 2 Results: Dual Evidence of Disease Modification<br \/>Objective Vascular Signs AND Patient Symptoms Improved<\/h4>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-3bed531 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"3bed531\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-72d9de5\" data-id=\"72d9de5\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-2039271 elementor-widget__width-initial elementor-widget elementor-widget-image\" data-id=\"2039271\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"2500\" height=\"1017\" src=\"https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/04\/CBT001-Effect-of-Treatment-Graph-with-Eyes.jpg\" class=\"attachment-full size-full wp-image-1369\" alt=\"\" srcset=\"https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/04\/CBT001-Effect-of-Treatment-Graph-with-Eyes.jpg 2500w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/04\/CBT001-Effect-of-Treatment-Graph-with-Eyes-300x122.jpg 300w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/04\/CBT001-Effect-of-Treatment-Graph-with-Eyes-1024x417.jpg 1024w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/04\/CBT001-Effect-of-Treatment-Graph-with-Eyes-768x312.jpg 768w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/04\/CBT001-Effect-of-Treatment-Graph-with-Eyes-1536x625.jpg 1536w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/04\/CBT001-Effect-of-Treatment-Graph-with-Eyes-2048x833.jpg 2048w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/04\/CBT001-Effect-of-Treatment-Graph-with-Eyes-18x7.jpg 18w\" sizes=\"(max-width: 2500px) 100vw, 2500px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-ef92e2c elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"ef92e2c\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-60e50a0\" data-id=\"60e50a0\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-c1a7c5b elementor-widget elementor-widget-spacer\" data-id=\"c1a7c5b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-47ec2dd elementor-widget elementor-widget-text-editor\" data-id=\"47ec2dd\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h3 style=\"text-align: center;\"><span style=\"color: #375e6f;\"><strong> KEY CLINICAL HIGHLIGHTS<\/strong><\/span><\/h3>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-e1a44d8 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"e1a44d8\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-33 elementor-top-column elementor-element elementor-element-79c4262\" data-id=\"79c4262\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-6ef7194 elementor-widget elementor-widget-image\" data-id=\"6ef7194\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"800\" height=\"125\" src=\"https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/cb-1920-bar-1024x160.jpg\" class=\"attachment-large size-large wp-image-1202\" alt=\"\" srcset=\"https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/cb-1920-bar-1024x160.jpg 1024w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/cb-1920-bar-300x47.jpg 300w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/cb-1920-bar-768x120.jpg 768w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/cb-1920-bar-1536x240.jpg 1536w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/cb-1920-bar-18x3.jpg 18w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/cb-1920-bar.jpg 1920w\" sizes=\"(max-width: 800px) 100vw, 800px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-8ed93f7 elementor-widget elementor-widget-text-editor\" data-id=\"8ed93f7\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h4 style=\"text-align: center;\"><strong>VASCULARITY REDUCTION<\/strong><\/h4><p style=\"text-align: left;\">Mean \u22120.8 grade reduction at Week 4 vs. no change for vehicle; treatment difference of \u22120.76 grade (p&lt;0.001)<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-33 elementor-top-column elementor-element elementor-element-41c7388\" data-id=\"41c7388\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-9817aff elementor-widget elementor-widget-image\" data-id=\"9817aff\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"800\" height=\"125\" src=\"https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/cb-1920-bar-1024x160.jpg\" class=\"attachment-large size-large wp-image-1202\" alt=\"\" srcset=\"https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/cb-1920-bar-1024x160.jpg 1024w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/cb-1920-bar-300x47.jpg 300w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/cb-1920-bar-768x120.jpg 768w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/cb-1920-bar-1536x240.jpg 1536w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/cb-1920-bar-18x3.jpg 18w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/cb-1920-bar.jpg 1920w\" sizes=\"(max-width: 800px) 100vw, 800px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-6015293 elementor-widget elementor-widget-text-editor\" data-id=\"6015293\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h4 style=\"text-align: center;\"><strong>LESION GROWTH HALTED<\/strong><\/h4><p style=\"text-align: left;\">3.3% reduction in lesion length vs. 8.0% increase in vehicle at Week 4 (p=0.006) \u00a0<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-33 elementor-top-column elementor-element elementor-element-e43d19f\" data-id=\"e43d19f\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-8e629a8 elementor-widget elementor-widget-image\" data-id=\"8e629a8\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"800\" height=\"125\" src=\"https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/cb-1920-bar-1024x160.jpg\" class=\"attachment-large size-large wp-image-1202\" alt=\"\" srcset=\"https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/cb-1920-bar-1024x160.jpg 1024w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/cb-1920-bar-300x47.jpg 300w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/cb-1920-bar-768x120.jpg 768w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/cb-1920-bar-1536x240.jpg 1536w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/cb-1920-bar-18x3.jpg 18w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/cb-1920-bar.jpg 1920w\" sizes=\"(max-width: 800px) 100vw, 800px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-f4ed7cd elementor-widget elementor-widget-text-editor\" data-id=\"f4ed7cd\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h4 style=\"text-align: center;\">WELL TOLERATED<\/h4><p style=\"text-align: left;\">Minimal systemic exposure (&gt;3,400\u00d7 lower than oral nintedanib); mild &amp; transient local AEs only<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-ed36df7 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"ed36df7\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-bcc1191\" data-id=\"bcc1191\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-1ef11db elementor-widget elementor-widget-text-editor\" data-id=\"1ef11db\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h3 style=\"text-align: center;\"><span style=\"color: #ffffff;\"><strong>Phase 2 Results: Dual Evidence of Disease Modification\u00a0<br \/>Objective Vascular Signs AND Patient Symptoms Improved<\/strong><\/span><\/h3>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-c903845 elementor-widget__width-initial elementor-widget elementor-widget-text-editor\" data-id=\"c903845\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><span style=\"color: #ffffff;\"><strong>PRIMARY ENDPOINT ACHIEVED<br \/><\/strong><span style=\"font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, 'Helvetica Neue', Arial, 'Noto Sans', sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol', 'Noto Color Emoji';\">CBT-001 0.2% demonstrated highly statistically significant reduction in pterygium vascularity (objective vascular measure) vs. vehicle at Week 4 (p &lt; 0.001)\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0<\/span><\/span><\/p><p><span style=\"color: #ffffff;\"><strong>PATIENT SYMPTOMS SIGNIFICANTLY IMPROVED\u00a0\u00a0\u00a0\u00a0\u00a0<\/strong> \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><br \/><span style=\"color: #ffffff;\">Ocular symptoms (including red eye, irritation, and discomfort) showed meaningful improvement across multiple PSLQ domains, with red eye symptom achieving statistical significance (p = 0.038) at Week 4<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-4a86637 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"4a86637\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-e6037be\" data-id=\"e6037be\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-7cb3592 elementor-widget elementor-widget-spacer\" data-id=\"7cb3592\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-33048ab elementor-widget elementor-widget-text-editor\" data-id=\"33048ab\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h2 style=\"text-align: center;\"><span style=\"color: #375e6f;\"><strong>PRIMARY ENDPOINT: PTERYGIUM VASCULARITY<\/strong><\/span><\/h2><h4 style=\"text-align: center;\"><strong>Objective Vascular Pathology<\/strong><\/h4>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-750f352 elementor-widget__width-initial elementor-widget elementor-widget-text-editor\" data-id=\"750f352\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><strong>What Was Measured:<\/strong> Pterygium vascularity \u2014 the characteristic &#8220;fleshy&#8221; fibrovascular tissue with prominent vessel network and vascular turgescence \u2014 was graded on a validated 5-point scale (0-4) by an independent reading center (Doheny Eye Institute) using standardized digital photography. As noted in the CSR:<\/p><p><em>&#8220;Pterygium vascularity grading assesses the vascular turgescence related to the severity of the fibrovascular proliferation, as highlighted by the vessel network morphology. <strong>This is of major interest because it drives the visual prognosis.<\/strong>&#8220;<\/em>\u00a0<\/p><p><strong>Week 4 Primary Endpoint Results \u2014 Pterygium Vascularity Grade Change from Baseline:<\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-a02feef elementor-widget__width-initial uael-header-sticky-no uael-border-yes elementor-widget elementor-widget-uael-table\" data-id=\"a02feef\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"uael-table.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div itemscope class=\"uael-table-wrapper\" itemtype=\"http:\/\/schema.org\/Table\">\n\t\t<table id=\"uael-table-id-a02feef\" class=\"uael-text-break uael-column-rules uael-table\" data-sort-table=\"no\" data-show-entry=\"no\" data-searchable=\"no\" data-responsive=\"no\">\n\t\t\t\t<thead>\n\t\t\t\t\t\t\t\t\t\t<tr class=\"uael-table-row\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t<th data-sort=\"0\" class=\"sort-this elementor-repeater-item-10f3ba5 uael-table-col uael-table-head-cell-text\" scope=\"col\">\n\t\t\t\t\t\t\t<span class=\"sort-style\">\n\t\t\t\t\t\t\t<span class=\"uael-table__text\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text-inner\">Treatment Group<\/span>\n\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<\/th>\n\t\t\t\t\t\t\t\t\t\t\t\t<th data-sort=\"1\" class=\"sort-this elementor-repeater-item-838da8c uael-table-col uael-table-head-cell-text\" scope=\"col\">\n\t\t\t\t\t\t\t<span class=\"sort-style\">\n\t\t\t\t\t\t\t<span class=\"uael-table__text\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text-inner\">Baseline Mean<\/span>\n\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<\/th>\n\t\t\t\t\t\t\t\t\t\t\t\t<th data-sort=\"2\" class=\"sort-this elementor-repeater-item-3876cbf uael-table-col uael-table-head-cell-text\" scope=\"col\">\n\t\t\t\t\t\t\t<span class=\"sort-style\">\n\t\t\t\t\t\t\t<span class=\"uael-table__text\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text-inner\">Mean Change from Baseline<\/span>\n\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<\/th>\n\t\t\t\t\t\t\t\t\t\t\t\t<th data-sort=\"3\" class=\"sort-this elementor-repeater-item-59aecd9 uael-table-col uael-table-head-cell-text\" scope=\"col\">\n\t\t\t\t\t\t\t<span class=\"sort-style\">\n\t\t\t\t\t\t\t<span class=\"uael-table__text\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text-inner\">Within-Group p-value<\/span>\n\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<\/th>\n\t\t\t\t\t\t\t\t\t\t\t\t<th data-sort=\"4\" class=\"sort-this elementor-repeater-item-9dff124 uael-table-col uael-table-head-cell-text\" scope=\"col\">\n\t\t\t\t\t\t\t<span class=\"sort-style\">\n\t\t\t\t\t\t\t<span class=\"uael-table__text\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text-inner\">Treatment Difference vs Vehicle<\/span>\n\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<\/th>\n\t\t\t\t\t\t\t\t\t\t\t\t<th data-sort=\"5\" class=\"sort-this elementor-repeater-item-895b0fa uael-table-col uael-table-head-cell-text\" scope=\"col\">\n\t\t\t\t\t\t\t<span class=\"sort-style\">\n\t\t\t\t\t\t\t<span class=\"uael-table__text\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text-inner\">Between-Group p-value<\/span>\n\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<\/th>\n\t\t\t\t\t\t\t\t<\/thead>\n\t\t\t\t<tbody>\n\t\t\t<!-- ROWS -->\n\t\t\t\t\t\t\t\t\t\t<tr data-entry=\"1\" class=\"uael-table-row\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<td class=\"uael-table-col uael-table-body-cell-text elementor-repeater-item-b2ea16c\" data-title=\"Treatment Group\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text-inner\">Vehicle Control<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<td class=\"uael-table-col uael-table-body-cell-text elementor-repeater-item-26a2587\" data-title=\"Baseline Mean\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text-inner\">3.0 \u00b1 0.8<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<td class=\"uael-table-col uael-table-body-cell-text elementor-repeater-item-a4cb005\" data-title=\"Mean Change from Baseline\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text-inner\">0.0 \u00b1 0.5<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<td class=\"uael-table-col uael-table-body-cell-text elementor-repeater-item-aa255a2\" data-title=\"Within-Group p-value\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text-inner\">p &gt; 0.999 (NS)<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<td class=\"uael-table-col uael-table-body-cell-text elementor-repeater-item-b828cf4\" data-title=\"Treatment Difference vs Vehicle\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text-inner\">\u2013\u2013\u2013<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<td class=\"uael-table-col uael-table-body-cell-text elementor-repeater-item-1e91437\" data-title=\"Between-Group p-value\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text-inner\">\u2013\u2013\u2013<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/tr><tr data-entry=\"2\" class=\"uael-table-row\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<td class=\"uael-table-col uael-table-body-cell-text elementor-repeater-item-0366c30\" data-title=\"Treatment Group\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text-inner\">CBT-001 0.2%<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<td class=\"uael-table-col uael-table-body-cell-text elementor-repeater-item-5a3734f\" data-title=\"Baseline Mean\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text-inner\">2.9 \u00b1 0.7<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<td class=\"uael-table-col uael-table-body-cell-text elementor-repeater-item-f662fd4\" data-title=\"Mean Change from Baseline\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text-inner\">-0.8 \u00b1 0.7<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<td class=\"uael-table-col uael-table-body-cell-text elementor-repeater-item-1750436\" data-title=\"Within-Group p-value\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text-inner\">p &lt; 0.001<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<td class=\"uael-table-col uael-table-body-cell-text elementor-repeater-item-2292fbc\" data-title=\"Treatment Difference vs Vehicle\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text-inner\">-0.76 grade<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<td class=\"uael-table-col uael-table-body-cell-text elementor-repeater-item-bf5b61d\" data-title=\"Between-Group p-value\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text-inner\">p &lt; 0.001<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/td>\n\t\t\t\t\t\t\t\t\t<\/tbody>\n\t<\/table>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-b8e0019 elementor-widget__width-initial elementor-widget elementor-widget-text-editor\" data-id=\"b8e0019\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><em>Note: Negative values indicate reduction in vascularity grade (improvement). Higher magnitude of reduction = greater efficacy.<\/em><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-0b006d1 elementor-widget elementor-widget-spacer\" data-id=\"0b006d1\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-980542b elementor-widget__width-initial elementor-widget elementor-widget-text-editor\" data-id=\"980542b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><strong>Key Clinical Findings:<\/strong><\/p><ol><li><strong>Highly Significant Primary Endpoint:<\/strong> At Week 4 (primary endpoint), CBT-001 0.2% demonstrated a mean vascularity reduction of <strong>-0.8 grade<\/strong> compared to <strong>no change (0.0)<\/strong> in the vehicle group<ul><li>Treatment difference: <strong>-0.76 grade<\/strong> (p &lt; 0.001)<\/li><li>This represents nearly a <strong>one full grade improvement<\/strong> in vascularity severity<\/li><\/ul><\/li><li><strong>Rapid Onset:<\/strong> Significant separation from vehicle was evident as early as Week 2 (-0.6 vs +0.1, p &lt; 0.001)<\/li><li><strong>Sustained Efficacy:<\/strong> Statistically significant treatment differences persisted through Week 16 (p \u2264 0.008)<\/li><li><strong>Clinically Meaningful Responder Rates:<\/strong><ul><li><strong>68% of CBT-001 patients<\/strong> showed \u22651 grade improvement at Week 4 vs <strong>only 13% of vehicle patients<\/strong> (p &lt; 0.001)<\/li><li><strong>60% responder rate<\/strong> as early as Week 2 vs <strong>0% in vehicle<\/strong> (p &lt; 0.001)<\/li><\/ul><\/li><\/ol>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-9c6a4ec elementor-widget elementor-widget-spacer\" data-id=\"9c6a4ec\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-13d961f elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"13d961f\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-1005ac8\" data-id=\"1005ac8\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-3a7734a elementor-widget__width-initial elementor-widget elementor-widget-text-editor\" data-id=\"3a7734a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h3 style=\"text-align: center;\"><strong>CBT-001 0.2% Ophthalmic Solution \u2014 Pterygium Vascularity Outcomes<\/strong><\/h3><p style=\"text-align: center;\">Phase 2 Randomized Controlled Trial \u00b7 Primary Endpoint: Week 4 \u00b7 Vascularity Score (0\u20134 scale)<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-596fac6 elementor-widget elementor-widget-image\" data-id=\"596fac6\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t<figure class=\"wp-caption\">\n\t\t\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"1792\" height=\"564\" src=\"https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/PT-Vascularity-Week-4-Truncated.jpg\" class=\"attachment-full size-full wp-image-1292\" alt=\"\" srcset=\"https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/PT-Vascularity-Week-4-Truncated.jpg 1792w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/PT-Vascularity-Week-4-Truncated-300x94.jpg 300w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/PT-Vascularity-Week-4-Truncated-1024x322.jpg 1024w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/PT-Vascularity-Week-4-Truncated-768x242.jpg 768w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/PT-Vascularity-Week-4-Truncated-1536x483.jpg 1536w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/PT-Vascularity-Week-4-Truncated-18x6.jpg 18w\" sizes=\"(max-width: 1792px) 100vw, 1792px\" \/>\t\t\t\t\t\t\t\t\t\t\t<figcaption class=\"widget-image-caption wp-caption-text\"><\/figcaption>\n\t\t\t\t\t\t\t\t\t\t<\/figure>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-ebc4055 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"ebc4055\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-76ea38c\" data-id=\"76ea38c\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-2badced elementor-widget elementor-widget-text-editor\" data-id=\"2badced\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h2 style=\"text-align: center;\"><span style=\"color: #375e6f;\"><strong>PATIENT-REPORTED SYMPTOMS: PSLQ QUESTIONNAIRE <\/strong><\/span><\/h2>\n<h3 style=\"text-align: center;\"><strong>(Subjective Quality of Life)<\/strong><\/h3>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-525551f elementor-widget elementor-widget-text-editor\" data-id=\"525551f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><strong>Why Patient Symptoms Are Critical:<\/strong><\/p><p><strong>Pterygium is not just an appearance issue<\/strong>\u00a0\u2014 it causes significant functional impairment and symptom burden. As documented in the CBT-001 CSR Introduction:<\/p><p><em>&#8220;Although pterygium is non-malignant, <strong>it can cause significant ocular symptoms, including hyperemia, irritation, pain, and foreign body sensation, thus it impacts the quality of patients&#8217; life.<\/strong>&#8220;<\/em> (Citing Jaros and DeLuise, 1988)<\/p><p>Beyond the visible vascular pathology that clinicians observe and grade, patients experience <strong>daily discomfort, visual disturbances, and quality-of-life impacts<\/strong> that drive treatment-seeking behavior and determine real-world therapeutic value.<\/p><p><strong>The PSLQ (Pterygium Symptom and Life Quality) Questionnaire:<\/strong><\/p><p>The PSLQ is a validated 15-question instrument derived from the Visual Functioning Questionnaire-25 (VFQ-25) and Ocular Surface Disease Index (OSDI). It assesses three critical domains:<\/p><ol><li><strong>Ocular Symptoms (6 questions):<\/strong> Frequency of eye redness, irritation, discomfort, foreign body sensation, and related symptoms<\/li><li><strong>Vision-Related Functioning (4 questions):<\/strong> Impact on daily visual tasks and activities<\/li><li><strong>Quality of Life Impact (5 questions):<\/strong> How pterygium affects overall quality of life, social interactions, and daily functioning<\/li><\/ol><p>Patients rated each symptom on a 5-point frequency scale (0 = none of the time; 4 = all the time), with lower scores indicating better outcomes.<\/p><p><strong>CBT-001 Phase 2 Results: PSLQ Outcomes<\/strong><\/p><p><strong>Overall PSLQ Score:<\/strong> While between-group differences did not reach statistical significance for overall PSLQ score, <strong>both CBT-001 and vehicle groups showed improvements from baseline<\/strong>, suggesting potential trial design effects (e.g., placebo response, natural variability). However, CBT-001 demonstrated:<\/p><ul><li><strong>Statistically significant within-group improvements<\/strong> at Weeks 2, 4, 8, 16, and 24 (p \u2264 0.024)<\/li><li><strong>Sustained benefit<\/strong> across all follow-up timepoints through 24 weeks<\/li><li><strong>Numerically greater improvements<\/strong> compared to vehicle at most timepoints<\/li><\/ul><p><strong>PSLQ Ocular Symptom Subscore:<\/strong><\/p><p>The Ocular Symptom domain \u2014 which captures the most direct symptom burden from pterygium (redness, irritation, discomfort, grittiness) \u2014 showed the same pattern:<\/p><ul><li><strong>CBT-001:<\/strong> Statistically significant improvements from baseline at Weeks 2, 4, 8, 16, 24 (p \u2264 0.024)<\/li><li><strong>Vehicle:<\/strong> Improvements only at Weeks 2, 4, 8 (p \u2264 0.035), with effects diminishing by Week 16<\/li><li><strong>Trend toward greater benefit<\/strong> with CBT-001 treatment despite not achieving between-group statistical significance<\/li><\/ul><p><strong>PSLQ Quality of Life Impact:<\/strong><\/p><p>At Week 8, CBT-001 showed <strong>statistically significantly greater improvement in Quality of Life Impact<\/strong> compared to vehicle (p &lt; 0.05), validating that vascular improvements translate into meaningful patient-centered outcomes.<\/p><p><strong>PSLQ Red Eye Symptom \u2014 SIGNIFICANT RESULT AT WEEK 4<\/strong><\/p><p><strong>Subset Analysis:<\/strong> Patients with Baseline Red Eye Score &gt;1 (Moderate-to-Severe Red Eye)<\/p><p>A clinically important subset analysis focused on patients who reported <strong>frequent red eye at baseline<\/strong> (score &gt;1, indicating red eye &#8220;half the time&#8221; to &#8220;all the time&#8221;). This subset represented patients with the most bothersome and visible symptom.<\/p><p><strong>Red Eye Symptom Results at Week 4 (Primary Endpoint):<\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-fb36d1f elementor-widget elementor-widget-image\" data-id=\"fb36d1f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"1784\" height=\"563\" src=\"https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/03\/PT-Responder-Rates-97.jpg\" class=\"attachment-full size-full wp-image-1321\" alt=\"\" srcset=\"https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/03\/PT-Responder-Rates-97.jpg 1784w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/03\/PT-Responder-Rates-97-300x95.jpg 300w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/03\/PT-Responder-Rates-97-1024x323.jpg 1024w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/03\/PT-Responder-Rates-97-768x242.jpg 768w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/03\/PT-Responder-Rates-97-1536x485.jpg 1536w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/03\/PT-Responder-Rates-97-18x6.jpg 18w\" sizes=\"(max-width: 1784px) 100vw, 1784px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-7229df8 uael-header-sticky-no uael-border-yes elementor-widget elementor-widget-uael-table\" data-id=\"7229df8\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"uael-table.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div itemscope class=\"uael-table-wrapper\" itemtype=\"http:\/\/schema.org\/Table\">\n\t\t<table id=\"uael-table-id-7229df8\" class=\"uael-text-break uael-column-rules uael-table\" data-sort-table=\"no\" data-show-entry=\"no\" data-searchable=\"no\" data-responsive=\"no\">\n\t\t\t\t<thead>\n\t\t\t\t\t\t\t\t\t\t<tr class=\"uael-table-row\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t<th data-sort=\"0\" class=\"sort-this elementor-repeater-item-10f3ba5 uael-table-col uael-table-head-cell-text\" scope=\"col\">\n\t\t\t\t\t\t\t<span class=\"sort-style\">\n\t\t\t\t\t\t\t<span class=\"uael-table__text\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text-inner\">Treatment Group<\/span>\n\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<\/th>\n\t\t\t\t\t\t\t\t\t\t\t\t<th data-sort=\"1\" class=\"sort-this elementor-repeater-item-838da8c uael-table-col uael-table-head-cell-text\" scope=\"col\">\n\t\t\t\t\t\t\t<span class=\"sort-style\">\n\t\t\t\t\t\t\t<span class=\"uael-table__text\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text-inner\">Patients with \u22651 Point Improvement<\/span>\n\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<\/th>\n\t\t\t\t\t\t\t\t\t\t\t\t<th data-sort=\"2\" class=\"sort-this elementor-repeater-item-3876cbf uael-table-col uael-table-head-cell-text\" scope=\"col\">\n\t\t\t\t\t\t\t<span class=\"sort-style\">\n\t\t\t\t\t\t\t<span class=\"uael-table__text\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text-inner\">Mean Red Eye Score Reduction<\/span>\n\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<\/th>\n\t\t\t\t\t\t\t\t<\/thead>\n\t\t\t\t<tbody>\n\t\t\t<!-- ROWS -->\n\t\t\t\t\t\t\t\t\t\t<tr data-entry=\"1\" class=\"uael-table-row\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<td class=\"uael-table-col uael-table-body-cell-text elementor-repeater-item-b2ea16c\" data-title=\"Treatment Group\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text-inner\">Vehicle Control<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<td class=\"uael-table-col uael-table-body-cell-text elementor-repeater-item-26a2587\" data-title=\"Patients with \u22651 Point Improvement\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text-inner\">7\/11 (64%)<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<td class=\"uael-table-col uael-table-body-cell-text elementor-repeater-item-a4cb005\" data-title=\"Mean Red Eye Score Reduction\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text-inner\">-1.6 points<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/tr><tr data-entry=\"2\" class=\"uael-table-row\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<td class=\"uael-table-col uael-table-body-cell-text elementor-repeater-item-0366c30\" data-title=\"Treatment Group\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text-inner\">CBT-001 0.2%<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<td class=\"uael-table-col uael-table-body-cell-text elementor-repeater-item-5a3734f\" data-title=\"Patients with \u22651 Point Improvement\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text-inner\">13\/14 (97%)<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<td class=\"uael-table-col uael-table-body-cell-text elementor-repeater-item-f662fd4\" data-title=\"Mean Red Eye Score Reduction\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text-inner\">-2.7 points<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/td>\n\t\t\t\t\t\t\t\t\t<\/tbody>\n\t<\/table>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-e26adcd elementor-widget elementor-widget-text-editor\" data-id=\"e26adcd\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><strong>Treatment Difference:<\/strong> <strong>-1.1 points<\/strong> (p = 0.038)<\/p><p><strong>Key Clinical Significance:<\/strong><\/p><ul><li><strong>93% responder rate<\/strong> in CBT-001 group vs 64% in vehicle<\/li><li><strong>Nearly double the symptom improvement<\/strong> (-2.7 vs -1.6 points)<\/li><li><strong>Statistically significant<\/strong> despite small sample size, demonstrating robust effect<\/li><li>Red eye is the <strong>most visible, socially impactful symptom<\/strong> for pterygium patients \u2014 improvement in this domain addresses both physical discomfort and cosmetic concerns<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-f6209a2 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"f6209a2\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-f0c0c30\" data-id=\"f0c0c30\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-9a9c5f4 elementor-widget elementor-widget-image\" data-id=\"9a9c5f4\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"1786\" height=\"554\" src=\"https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/03\/PT-Symptom-Score-Graph.jpg\" class=\"attachment-full size-full wp-image-1320\" alt=\"\" srcset=\"https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/03\/PT-Symptom-Score-Graph.jpg 1786w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/03\/PT-Symptom-Score-Graph-300x93.jpg 300w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/03\/PT-Symptom-Score-Graph-1024x318.jpg 1024w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/03\/PT-Symptom-Score-Graph-768x238.jpg 768w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/03\/PT-Symptom-Score-Graph-1536x476.jpg 1536w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/03\/PT-Symptom-Score-Graph-18x6.jpg 18w\" sizes=\"(max-width: 1786px) 100vw, 1786px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-e37f9f6 elementor-widget elementor-widget-text-editor\" data-id=\"e37f9f6\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><em>Red eye \u2014 the most visibly apparent and socially impactful symptom of pterygium \u2014 showed statistically significant improvement with CBT-001 treatment. This dual impact on both vascular pathology (vascularity grade) and symptom burden (red eye, ocular discomfort) validates CBT-001&#8217;s disease-modifying potential across the full spectrum of pterygium manifestations.<\/em><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-78ead31 elementor-widget elementor-widget-text-editor\" data-id=\"78ead31\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h2 style=\"text-align: center;\"><span style=\"color: #375e6f;\"><strong>KEY CLINICAL HIGHLIGHTS<\/strong><\/span><\/h2>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-1e877bd elementor-widget__width-initial uael-header-sticky-no uael-border-yes elementor-widget elementor-widget-uael-table\" data-id=\"1e877bd\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"uael-table.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div itemscope class=\"uael-table-wrapper\" itemtype=\"http:\/\/schema.org\/Table\">\n\t\t<table id=\"uael-table-id-1e877bd\" class=\"uael-text-break uael-column-rules uael-table\" data-sort-table=\"no\" data-show-entry=\"no\" data-searchable=\"no\" data-responsive=\"no\">\n\t\t\t\t<thead>\n\t\t\t\t\t\t\t\t\t\t<tr class=\"uael-table-row\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t<th data-sort=\"0\" class=\"sort-this elementor-repeater-item-10f3ba5 uael-table-col uael-table-head-cell-text\" scope=\"col\">\n\t\t\t\t\t\t\t<span class=\"sort-style\">\n\t\t\t\t\t\t\t<span class=\"uael-table__text\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text-inner\">Vascularity<\/span>\n\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<\/th>\n\t\t\t\t\t\t\t\t\t\t\t\t<th data-sort=\"1\" class=\"sort-this elementor-repeater-item-838da8c uael-table-col uael-table-head-cell-text\" scope=\"col\">\n\t\t\t\t\t\t\t<span class=\"sort-style\">\n\t\t\t\t\t\t\t<span class=\"uael-table__text\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text-inner\">Symptoms<\/span>\n\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<\/th>\n\t\t\t\t\t\t\t\t\t\t\t\t<th data-sort=\"2\" class=\"sort-this elementor-repeater-item-3876cbf uael-table-col uael-table-head-cell-text\" scope=\"col\">\n\t\t\t\t\t\t\t<span class=\"sort-style\">\n\t\t\t\t\t\t\t<span class=\"uael-table__text\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text-inner\">Responder Rate<\/span>\n\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<\/th>\n\t\t\t\t\t\t\t\t\t\t\t\t<th data-sort=\"3\" class=\"sort-this elementor-repeater-item-59aecd9 uael-table-col uael-table-head-cell-text\" scope=\"col\">\n\t\t\t\t\t\t\t<span class=\"sort-style\">\n\t\t\t\t\t\t\t<span class=\"uael-table__text\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text-inner\">Rapid Onset<\/span>\n\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<\/th>\n\t\t\t\t\t\t\t\t\t\t\t\t<th data-sort=\"4\" class=\"sort-this elementor-repeater-item-9dff124 uael-table-col uael-table-head-cell-text\" scope=\"col\">\n\t\t\t\t\t\t\t<span class=\"sort-style\">\n\t\t\t\t\t\t\t<span class=\"uael-table__text\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text-inner\">Well-tolerated<\/span>\n\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<\/th>\n\t\t\t\t\t\t\t\t<\/thead>\n\t\t\t\t<tbody>\n\t\t\t<!-- ROWS -->\n\t\t\t\t\t\t\t\t\t\t<tr data-entry=\"1\" class=\"uael-table-row\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/tr><tr data-entry=\"2\" class=\"uael-table-row\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<td class=\"uael-table-col uael-table-body-cell-text elementor-repeater-item-0366c30\" data-title=\"Vascularity\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text-inner\">Highly significant reduction in separation in pterygium vascularity at Week 4\n\n\u2022 -0.8 grade vs 0.0\n\n\u2022 p &lt; 0.001<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<td class=\"uael-table-col uael-table-body-cell-text elementor-repeater-item-5a3734f\" data-title=\"Symptoms\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text-inner\">Red eye symptom (most visible, bothersome symptom) showed significant improvement (93% responder rate)    <\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<td class=\"uael-table-col uael-table-body-cell-text elementor-repeater-item-f662fd4\" data-title=\"Responder Rate\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text-inner\">68% of patients showed &gt;1 grade vascularity improvement at Week 4 vs only 13% vehicle (p&lt;0.001)<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<td class=\"uael-table-col uael-table-body-cell-text elementor-repeater-item-1750436\" data-title=\"Rapid Onset\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text-inner\">Significant separation from vehicle as early as Week 2 (p&lt;0.001), with sustained benefit through Week 16         <\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<td class=\"uael-table-col uael-table-body-cell-text elementor-repeater-item-2292fbc\" data-title=\"Well-tolerated\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"uael-table__text-inner\">No systemic safety concerns; mild and transient local AEs only         <\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/td>\n\t\t\t\t\t\t\t\t\t<\/tbody>\n\t<\/table>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-b780746 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"b780746\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-9894e34\" data-id=\"9894e34\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-6bf101d elementor-widget elementor-widget-text-editor\" data-id=\"6bf101d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h2 style=\"text-align: center;\"><span style=\"color: #ffffff;\"><strong>CLINICAL SIGNIFICANCE STATEMENT<\/strong><\/span><\/h2><p style=\"text-align: center;\"><span style=\"color: #ffffff;\"><strong>DUAL EVIDENCE OF DISEASE MODIFICATION\u00a0 \u00a0<\/strong> \u00a0 \u00a0\u00a0<\/span><br \/><span style=\"color: #ffffff;\">CBT-001 is the first pharmacologic treatment to demonstrate disease modification in pterygium across BOTH:<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-bc3de27 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"bc3de27\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-33 elementor-top-column elementor-element elementor-element-55a930a\" data-id=\"55a930a\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap\">\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-33 elementor-top-column elementor-element elementor-element-42b2d06\" data-id=\"42b2d06\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-a7d0b79 elementor-widget elementor-widget-text-editor\" data-id=\"a7d0b79\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h5><span style=\"color: #ffffff;\"><strong>OBJECTIVE VASCULAR PATHOLOGY <\/strong>(Pterygium Vascularity)<\/span><\/h5><p><span style=\"color: #ffffff;\">\u00a0 \u00a0 \u00a0\u2713 Highly significant vascularity reduction (-0.8 grade, p&lt;0.001 at Week 4)<\/span><\/p><p><span style=\"color: #ffffff;\">\u00a0\u00a0\u00a0\u00a0 \u2713 Independent reading center grading ensures unbiased assessment<\/span><\/p><p><span style=\"color: #ffffff;\">\u00a0\u00a0\u00a0\u00a0 \u2713 68% responder rate (\u22651 grade improvement) vs 13% vehicle<\/span><\/p><p><span style=\"color: #ffffff;\">\u00a0\u00a0\u00a0\u00a0 \u2713 Addresses the visible fibrovascular proliferation that drives visual threat<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-33 elementor-top-column elementor-element elementor-element-0f7c0e6\" data-id=\"0f7c0e6\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap\">\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-5b982f0 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"5b982f0\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-33 elementor-top-column elementor-element elementor-element-3004957\" data-id=\"3004957\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap\">\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-33 elementor-top-column elementor-element elementor-element-b4230ff\" data-id=\"b4230ff\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-1fa45cb elementor-widget__width-initial elementor-widget elementor-widget-text-editor\" data-id=\"1fa45cb\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h5><span style=\"color: #ffffff;\"><strong>PATIENT-REPORTED SYMPTOM BURDEN <\/strong>(PSLQ Outcomes)<\/span><\/h5><p><span style=\"color: #ffffff;\">\u00a0\u00a0\u00a0\u00a0 \u2713 Red eye symptom significantly improved (p=0.038, 93% responder rate)<\/span><\/p><p><span style=\"color: #ffffff;\">\u00a0\u00a0\u00a0\u00a0 \u2713 Ocular symptoms showed sustained improvements through 24 weeks<\/span><\/p><p><span style=\"color: #ffffff;\">\u00a0\u00a0\u00a0\u00a0 \u2713 Quality of Life Impact significantly better than vehicle at Week 8<\/span><\/p><p><span style=\"color: #ffffff;\">\u00a0\u00a0\u00a0\u00a0 \u2713 Validates real-world benefit addressing both discomfort and cosmetic concern\u00a0<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-33 elementor-top-column elementor-element elementor-element-5eb2493\" data-id=\"5eb2493\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap\">\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-aa934e0 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"aa934e0\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-33 elementor-top-column elementor-element elementor-element-680cef6\" data-id=\"680cef6\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap\">\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-33 elementor-top-column elementor-element elementor-element-587e732\" data-id=\"587e732\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-34f2751 elementor-widget__width-initial elementor-widget elementor-widget-text-editor\" data-id=\"34f2751\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p style=\"text-align: left;\"><strong><em><span style=\"color: #ffffff;\">This dual impact demonstrates that CBT-001&#8217;s multi-kinase inhibitor platform addresses root pathophysiology \u2014 not just cosmetic appearance \u2014 delivering meaningful clinical benefit across the disease spectrum: vascular pathology, symptom burden, quality of life, and visual prognosis.<\/span><\/em><\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-33 elementor-top-column elementor-element elementor-element-fbd3e51\" data-id=\"fbd3e51\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap\">\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-b7ab4d5 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"b7ab4d5\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-d54911f\" data-id=\"d54911f\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-6ce320d elementor-widget elementor-widget-text-editor\" data-id=\"6ce320d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h2 style=\"text-align: center;\"><span style=\"color: #375e6f;\"><strong>ADDRESSING CRITICAL UNMET NEED <\/strong><\/span><\/h2>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-8590fdc elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"8590fdc\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-ed2a60b\" data-id=\"ed2a60b\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-03f6b3a elementor-widget elementor-widget-text-editor\" data-id=\"03f6b3a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>The Problem<\/strong> Over 400 million people worldwide suffer from pterygium, yet no FDA-approved pharmacological treatment exists. Current options \u2014 topical steroids, NSAIDs, and surgical excision \u2014 offer only temporary relief or mechanical removal, leaving the underlying vascular and fibrotic drivers of the disease unaddressed.<\/p><p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>The Solution<\/strong> CBT-001 (nintedanib) is the first topical therapy to simultaneously target VEGFR, PDGFR, and FGFR \u2014 the core pathways driving pterygium&#8217;s progression. The clinical data presented here demonstrate its ability to reduce vascularity, inhibit lesion growth, and address the root cause of a condition that has gone untreated for far too long.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-cc515c6 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"cc515c6\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-623fd49\" data-id=\"623fd49\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-72f00d1 elementor-widget elementor-widget-text-editor\" data-id=\"72f00d1\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h2 style=\"text-align: center;\"><span style=\"color: #ffffff;\"><strong>Why This Matters to People with Pterygium,<br \/>Professionals and Investors<\/strong><\/span><\/h2>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-1bc07ad elementor-widget elementor-widget-text-editor\" data-id=\"1bc07ad\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<span style=\"color: #ffffff;\">Pterygium is a chronic, symptomatic eye disease that affects quality of life, clinical practice, and healthcare economics. It is more than an issue of appearance. Understanding its impact across these groups underscores the need for a targeted therapeutic approach that goes beyond temporary symptom relief to address the underlying disease process and potentially change its long\u2011term course.<\/span>\n\n<span style=\"color: #ffffff;\">At Cloudbreak Pharma, we have Phase 3 candidates in development specifically designed to intervene earlier in this disease, to reduce symptoms, slow progression, and ultimately lessen the need for surgery.<\/span>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-f91e988 elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"f91e988\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-adfd046 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"adfd046\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-33 elementor-top-column elementor-element elementor-element-0aa800a\" data-id=\"0aa800a\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-6f2ab30 elementor-widget elementor-widget-text-editor\" data-id=\"6f2ab30\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h3 style=\"text-align: center;\"><span style=\"color: #ffffff;\"><strong>People with Pterygium<\/strong><\/span><\/h3>\n<p style=\"text-align: center;\"><span style=\"color: #ffffff;\">Find out more about the causes of pterygium and current management options<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-9e298dd elementor-align-center elementor-widget elementor-widget-button\" data-id=\"9e298dd\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"#\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Learn more<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-33 elementor-top-column elementor-element elementor-element-e3f6a09\" data-id=\"e3f6a09\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-90ca1f9 elementor-widget elementor-widget-text-editor\" data-id=\"90ca1f9\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h3 style=\"text-align: center;\"><span style=\"color: #ffffff;\"><strong>Professionals<\/strong><\/span><\/h3>\n<p style=\"text-align: center;\"><span style=\"color: #ffffff;\">Find out how Multi-Kinase Inhibitors may represent the first disease modifying approach to treating pterygium<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-5f9dabb elementor-align-center elementor-widget elementor-widget-button\" data-id=\"5f9dabb\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"#\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Learn more<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-33 elementor-top-column elementor-element elementor-element-f352817\" data-id=\"f352817\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-0d61165 elementor-widget elementor-widget-text-editor\" data-id=\"0d61165\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h3 style=\"text-align: center;\"><span style=\"color: #ffffff;\"><strong>Investors<\/strong><\/span><\/h3>\n<p style=\"text-align: center;\"><span style=\"color: #ffffff;\">Find out more about Cloudbreak Pharma as a potential investment opportunity on the Hong Kong Stock Exchange (2592.HK)<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-7276533 elementor-align-center elementor-widget elementor-widget-button\" data-id=\"7276533\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"#\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Learn more<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-2e0a056 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"2e0a056\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-9c52e10\" data-id=\"9c52e10\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap\">\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>First Pharmacologic Approach to Target Pterygium\u2019s Root Cause Cloudbreak Pharma is pioneering the first FDA-approvable pharmaceutical treatment for pterygium \u2014 a condition affecting over 15 million people in the U.S. with no approved pharmacological options. Our lead program, CBT-001, is a proprietary Multi-Kinase Inhibitor (MKI) eye drop designed to simultaneously target the multiple signaling pathways [&hellip;]<\/p>\n","protected":false},"author":16,"featured_media":0,"parent":998,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-1224","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pterygium Therapy - Cloudbreak Pharma, Inc.<\/title>\n<meta name=\"description\" content=\"Unmet needs in pterygium management? Learn more about the disease, current treatments, and explore the targeted therapeutic approach during trials\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cloudbreakpharma.com\/zh_hk\/our-focus\/pterygium-therapy\/\" \/>\n<meta property=\"og:locale\" content=\"zh_HK\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pterygium Therapy - Cloudbreak Pharma, Inc.\" \/>\n<meta property=\"og:description\" content=\"Unmet needs in pterygium management? Learn more about the disease, current treatments, and explore the targeted therapeutic approach during trials\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cloudbreakpharma.com\/zh_hk\/our-focus\/pterygium-therapy\/\" \/>\n<meta property=\"og:site_name\" content=\"Cloudbreak Pharma, Inc.\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-02T21:01:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/CB-PT-Eyedropper-with-PT-square.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1247\" \/>\n\t<meta property=\"og:image:height\" content=\"1247\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u9810\u8a08\u95b1\u8b80\u6642\u9593\" \/>\n\t<meta name=\"twitter:data1\" content=\"10 \u5206\u9418\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/cloudbreakpharma.com\\\/our-focus\\\/pterygium-therapy\\\/\",\"url\":\"https:\\\/\\\/cloudbreakpharma.com\\\/our-focus\\\/pterygium-therapy\\\/\",\"name\":\"Pterygium Therapy - Cloudbreak Pharma, Inc.\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cloudbreakpharma.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/cloudbreakpharma.com\\\/our-focus\\\/pterygium-therapy\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/cloudbreakpharma.com\\\/our-focus\\\/pterygium-therapy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cloudbreakpharma.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/CB-PT-Eyedropper-with-PT-square-1024x1024.jpg\",\"datePublished\":\"2026-02-12T22:37:09+00:00\",\"dateModified\":\"2026-04-02T21:01:46+00:00\",\"description\":\"Unmet needs in pterygium management? Learn more about the disease, current treatments, and explore the targeted therapeutic approach during trials\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/cloudbreakpharma.com\\\/our-focus\\\/pterygium-therapy\\\/#breadcrumb\"},\"inLanguage\":\"zh-HK\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/cloudbreakpharma.com\\\/our-focus\\\/pterygium-therapy\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-HK\",\"@id\":\"https:\\\/\\\/cloudbreakpharma.com\\\/our-focus\\\/pterygium-therapy\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cloudbreakpharma.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/CB-PT-Eyedropper-with-PT-square-1024x1024.jpg\",\"contentUrl\":\"https:\\\/\\\/cloudbreakpharma.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/CB-PT-Eyedropper-with-PT-square-1024x1024.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/cloudbreakpharma.com\\\/our-focus\\\/pterygium-therapy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/cloudbreakpharma.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Our Focus\",\"item\":\"https:\\\/\\\/cloudbreakpharma.com\\\/our-focus\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Pterygium Therapy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/cloudbreakpharma.com\\\/#website\",\"url\":\"https:\\\/\\\/cloudbreakpharma.com\\\/\",\"name\":\"Cloudbreak Pharma, Inc.\",\"description\":\"Seeing Life Better Through Medicine\",\"publisher\":{\"@id\":\"https:\\\/\\\/cloudbreakpharma.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/cloudbreakpharma.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-HK\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/cloudbreakpharma.com\\\/#organization\",\"name\":\"Cloudbreak Pharma, Inc.\",\"url\":\"https:\\\/\\\/cloudbreakpharma.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-HK\",\"@id\":\"https:\\\/\\\/cloudbreakpharma.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/cloudbreakpharma.com\\\/wp-content\\\/uploads\\\/2022\\\/08\\\/cloudbreak-logo.svg\",\"contentUrl\":\"https:\\\/\\\/cloudbreakpharma.com\\\/wp-content\\\/uploads\\\/2022\\\/08\\\/cloudbreak-logo.svg\",\"width\":824,\"height\":199,\"caption\":\"Cloudbreak Pharma, Inc.\"},\"image\":{\"@id\":\"https:\\\/\\\/cloudbreakpharma.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pterygium Therapy - Cloudbreak Pharma, Inc.","description":"Unmet needs in pterygium management? Learn more about the disease, current treatments, and explore the targeted therapeutic approach during trials","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cloudbreakpharma.com\/zh_hk\/our-focus\/pterygium-therapy\/","og_locale":"zh_HK","og_type":"article","og_title":"Pterygium Therapy - Cloudbreak Pharma, Inc.","og_description":"Unmet needs in pterygium management? Learn more about the disease, current treatments, and explore the targeted therapeutic approach during trials","og_url":"https:\/\/cloudbreakpharma.com\/zh_hk\/our-focus\/pterygium-therapy\/","og_site_name":"Cloudbreak Pharma, Inc.","article_modified_time":"2026-04-02T21:01:46+00:00","og_image":[{"width":1247,"height":1247,"url":"https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/CB-PT-Eyedropper-with-PT-square.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"\u9810\u8a08\u95b1\u8b80\u6642\u9593":"10 \u5206\u9418"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cloudbreakpharma.com\/our-focus\/pterygium-therapy\/","url":"https:\/\/cloudbreakpharma.com\/our-focus\/pterygium-therapy\/","name":"Pterygium Therapy - Cloudbreak Pharma, Inc.","isPartOf":{"@id":"https:\/\/cloudbreakpharma.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cloudbreakpharma.com\/our-focus\/pterygium-therapy\/#primaryimage"},"image":{"@id":"https:\/\/cloudbreakpharma.com\/our-focus\/pterygium-therapy\/#primaryimage"},"thumbnailUrl":"https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/CB-PT-Eyedropper-with-PT-square-1024x1024.jpg","datePublished":"2026-02-12T22:37:09+00:00","dateModified":"2026-04-02T21:01:46+00:00","description":"Unmet needs in pterygium management? Learn more about the disease, current treatments, and explore the targeted therapeutic approach during trials","breadcrumb":{"@id":"https:\/\/cloudbreakpharma.com\/our-focus\/pterygium-therapy\/#breadcrumb"},"inLanguage":"zh-HK","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cloudbreakpharma.com\/our-focus\/pterygium-therapy\/"]}]},{"@type":"ImageObject","inLanguage":"zh-HK","@id":"https:\/\/cloudbreakpharma.com\/our-focus\/pterygium-therapy\/#primaryimage","url":"https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/CB-PT-Eyedropper-with-PT-square-1024x1024.jpg","contentUrl":"https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/02\/CB-PT-Eyedropper-with-PT-square-1024x1024.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/cloudbreakpharma.com\/our-focus\/pterygium-therapy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cloudbreakpharma.com\/"},{"@type":"ListItem","position":2,"name":"Our Focus","item":"https:\/\/cloudbreakpharma.com\/our-focus\/"},{"@type":"ListItem","position":3,"name":"Pterygium Therapy"}]},{"@type":"WebSite","@id":"https:\/\/cloudbreakpharma.com\/#website","url":"https:\/\/cloudbreakpharma.com\/","name":"Cloudbreak Pharma, Inc.","description":"\u91ab\u85e5\u4f7f\u6211\u5011\u80fd\u66f4\u597d\u7684\u8996\u89ba\u4eab\u53d7\u751f\u6d3b","publisher":{"@id":"https:\/\/cloudbreakpharma.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cloudbreakpharma.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-HK"},{"@type":"Organization","@id":"https:\/\/cloudbreakpharma.com\/#organization","name":"Cloudbreak Pharma, Inc.","url":"https:\/\/cloudbreakpharma.com\/","logo":{"@type":"ImageObject","inLanguage":"zh-HK","@id":"https:\/\/cloudbreakpharma.com\/#\/schema\/logo\/image\/","url":"https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2022\/08\/cloudbreak-logo.svg","contentUrl":"https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2022\/08\/cloudbreak-logo.svg","width":824,"height":199,"caption":"Cloudbreak Pharma, Inc."},"image":{"@id":"https:\/\/cloudbreakpharma.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/pages\/1224","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/comments?post=1224"}],"version-history":[{"count":0,"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/pages\/1224\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/pages\/998"}],"wp:attachment":[{"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/media?parent=1224"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}